Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
4
Neutral
8
Bullish
2
Bearish
4
Neutral
28
Bullish
14
Bearish
0
Neutral
20
Bullish
12
Ganga Pharmaceuticals Ltd manufactures and trades ayurvedic pharmaceuticals, focusing on traditional medicine with a modern approach.
Established in 1994, the company took over an existing ayurvedic business in 1995, signifying a strong foundation in traditional medicine.
The company has a global presence, exporting its products to countries in the Middle East and Europe, indicating a robust international market penetration.
It has invested in expanding manufacturing capabilities, emphasizing a commitment to innovation and meeting increasing demand.
Despite its extensive history, the absence of recent strategic updates raises questions about its current competitive positioning.
Pharmaceuticals
Pharmaceuticals - Indian - Formulations
7 Cr
Low Risk
89.9
43.8
3.2
0.9
19.20
9.25
Sales CAGR
1Y
-3.65%
3Y
1.95%
5Y
-3.05%
10Y
-0.26%
Profit CAGR
1Y
60.00%
3Y
27.77%
5Y
-15.98%
10Y
5.53%
ROE
TTM
0.96%
3Y
0.84%
5Y
0.73%
10Y
1.47%
ROCE
TTM
2.20%
3Y
3.67%
5Y
3.74%
10Y
5.53%
Investor Presentation
Q4 FY24
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
MODERATE RISK
Market Cap
₹ 7 Cr
P/E
89.85
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
52.60 | 22 Cr | 48.65 | 1.88 | 0.00 | 4.69 | 5.88 | 3.79 | |
33.77 | 19 Cr | 29.37 | 1.52 | 0.00 | 5.08 | 7.80 | 3.39 | |
3.51 | 19 Cr | — | 2.46 | 0.00 | -0.79 | 1.96 | -0.56 | |
24.98 | 11 Cr | 10.95 | 2.59 | 0.00 | 23.59 | 26.37 | 15.81 | |
11.68 | 7 Cr | 89.85 | 0.86 | 0.00 | 0.96 | 2.20 | 0.79 | |
8.37 | 5 Cr | — | 0.00 | 0.00 | 2.30 | 33.90 | -25.00 | |
1.77 | 3 Cr | — | 5.24 | 0.00 | -138.58 | -10.61 | -9.90 |
